FTC sues main pharmacy benefit professionals around insulin prices The agency introduced action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing cost of life-saving insulin prescription drugs. Since some electronic overall health startups funded throughout the peak from the financial https://cruzrhxne.look4blog.com/69395916/a-simple-key-for-healthcare-news-unveiled